Quinoline-derived amide modulators of vanilloid VR1 receptor
申请人:——
公开号:US20040192728A1
公开(公告)日:2004-09-30
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.